BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37210794)

  • 1. Investigating the folding dynamics of NS2B protein of Zika virus.
    Kumar A; Kumar P; Mishra PM; Giri R
    Virology; 2023 Jul; 584():24-36. PubMed ID: 37210794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zika Virus NS2A-Mediated Virion Assembly.
    Zhang X; Xie X; Xia H; Zou J; Huang L; Popov VL; Chen X; Shi PY
    mBio; 2019 Oct; 10(5):. PubMed ID: 31662457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic Interactions of Post Cleaved NS2B Cofactor and NS3 Protease Identified by Integrative Structural Approaches.
    Quek JP; Ser Z; Chew BLA; Li X; Wang L; Sobota RM; Luo D; Phoo WW
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating into the molecular interactions of flavonoids targeting NS2B-NS3 protease from ZIKA virus through
    Yadav R; Selvaraj C; Aarthy M; Kumar P; Kumar A; Singh SK; Giri R
    J Biomol Struct Dyn; 2021 Jan; 39(1):272-284. PubMed ID: 31920173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of molecular interactions between Zika virus protease and peptides derived from the C-terminus of NS2B.
    Li Y; Loh YR; Hung AW; Kang C
    Biochem Biophys Res Commun; 2018 Sep; 503(2):691-696. PubMed ID: 29908184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MD simulations reveal alternate conformations of the oxyanion hole in the Zika virus NS2B/NS3 protease.
    Ren J; Lee H; Kotak A; Johnson ME
    Proteins; 2020 Feb; 88(2):345-354. PubMed ID: 31461176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric quinoxaline-based inhibitors of the flavivirus NS2B/NS3 protease.
    Zephyr J; Rao DN; Johnson C; Shaqra AM; Nalivaika EA; Jordan A; Kurt Yilmaz N; Ali A; Schiffer CA
    Bioorg Chem; 2023 Feb; 131():106269. PubMed ID: 36446201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of NS2B-NS3 protease inhibitor that impairs Zika virus replication.
    Lin WW; Huang YJ; Wang YT; Lin YS; Mazibuko N; Chen CS; Cheng TL; Chang CS; Leu YL; Chen CY; Chuang CH
    Virus Res; 2023 May; 329():199092. PubMed ID: 36965673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zika NS2B is a crucial factor recruiting NS3 to the ER and activating its protease activity.
    Xing H; Xu S; Jia F; Yang Y; Xu C; Qin C; Shi L
    Virus Res; 2020 Jan; 275():197793. PubMed ID: 31676367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of the NS2B-NS3 protease from Zika virus after self-cleavage.
    Phoo WW; Li Y; Zhang Z; Lee MY; Loh YR; Tan YB; Ng EY; Lescar J; Kang C; Luo D
    Nat Commun; 2016 Nov; 7():13410. PubMed ID: 27845325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The discovery of Zika virus NS2B-NS3 inhibitors with antiviral activity via an integrated virtual screening approach.
    Mirza MU; Alanko I; Vanmeert M; Muzzarelli KM; Salo-Ahen OMH; Abdullah I; Kovari IA; Claes S; De Jonghe S; Schols D; Schinazi RF; Kovari LC; Trant JF; Ahmad S; Froeyen M
    Eur J Pharm Sci; 2022 Aug; 175():106220. PubMed ID: 35618201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design of a novel inhibitor of the ZIKA virus NS2B/NS3 protease.
    Xiong Y; Cheng F; Zhang J; Su H; Hu H; Zou Y; Li M; Xu Y
    Bioorg Chem; 2022 Nov; 128():106109. PubMed ID: 36049322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experiments and simulation on ZIKV NS2B-NS3 protease reveal its complex folding.
    Kumar A; Kumar P; Aarthy M; Singh SK; Giri R
    Virology; 2021 Apr; 556():110-123. PubMed ID: 33561698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Montelukast as flavivirus NS2B-NS3 protease inhibitor by inverse virtual screening and experimental validation.
    Jiang H; Zhang Y; Wu Y; Cheng J; Feng S; Wang J; Wang X; Cheng M
    Biochem Biophys Res Commun; 2022 May; 606():87-93. PubMed ID: 35339757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structures and dynamics of peptide and peptidomimetic inhibitors bound to the NS2B-NS3 protease of the ZIKA virus.
    Pant S; Bhattacharya G; Jena NR
    J Biomol Struct Dyn; 2023 Apr; 41(7):3076-3088. PubMed ID: 35238272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Non-Active-Site Inhibitor with Selectivity for Zika Virus NS2B-NS3 Protease.
    Cruz KG; Hill Eron M; Makhaik S; Savinov S; Hardy JA
    ACS Infect Dis; 2024 Feb; 10(2):412-425. PubMed ID: 38265226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Structure of the Zika Virus Protease, NS2B/NS3
    Hilgenfeld R; Lei J; Zhang L
    Adv Exp Med Biol; 2018; 1062():131-145. PubMed ID: 29845530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric Inhibitors of Zika Virus NS2B-NS3 Protease Targeting Protease in "Super-Open" Conformation.
    Meewan I; Shiryaev SA; Kattoula J; Huang CT; Lin V; Chuang CH; Terskikh AV; Abagyan R
    Viruses; 2023 Apr; 15(5):. PubMed ID: 37243192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cis autocatalytic cleavage of glycine-linked Zika virus NS2B-NS3 protease constructs.
    von Hammerstein F; Lauth LM; Hammerschmidt S; Wagner A; Schirmeister T; Hellmich UA
    FEBS Lett; 2019 Aug; 593(16):2204-2213. PubMed ID: 31240714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of cellular proteome changes in response to ZIKV NS2B-NS3 protease expression.
    Tangsongcharoen C; Roytrakul S; Smith DR
    Biochim Biophys Acta Proteins Proteom; 2019 Feb; 1867(2):89-97. PubMed ID: 30391636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.